WealthCollab’s Royalty Pharma RPRX Stock Holding History

WealthCollab’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.52K	Hold	45	–	–	﹤0.01%	836
2026 Q1	$2.16K	Hold	45	–	–	﹤0.01%	829
2025 Q4	$1.74K	Hold	45	–	–	﹤0.01%	909
2025 Q3	$1.59K	Buy	+45	New	+$1.63K	﹤0.01%	868
2024 Q4	–	Sell	-69	Closed	-$1.95K	–	928
2024 Q3	$1.95K	Buy	+69	New	+$1.91K	﹤0.01%	777

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WealthCollab's RPRX Position: Q2 2026 in Review

WealthCollab held its Royalty Pharma (RPRX) position steady in Q2 2026 at 45 shares worth $2.52K. The position accounts for ﹤0.01% of the portfolio, ranked #836.

WealthCollab first reported a position in RPRX in Q3 2024 and has held it in 5 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

WealthCollab held 45 shares of Royalty Pharma worth $2.52K as of Q2 2026.
WealthCollab left its Royalty Pharma share count unchanged in Q2 2026.
Royalty Pharma made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #836 holding.
WealthCollab first reported a position in Royalty Pharma in Q3 2024 and has held it in 5 quarters since.
646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.